טוען...
Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?
Acute kidney injury (AKI) is a common and serious complication in hospitalized patients, which continues to pose a clinical challenge for treating physicians. The most recent Kidney Disease Improving Global Outcomes practice guidelines for AKI have restated the importance of earliest possible detect...
שמור ב:
| הוצא לאור ב: | Ann Lab Med |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Society for Laboratory Medicine
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7443517/ https://ncbi.nlm.nih.gov/pubmed/32829575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3343/alm.2021.41.1.1 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|